##gff-version 3 Q5S006 UniProtKB Chain 1 2527 . . . ID=PRO_0000086239;Note=Leucine-rich repeat serine/threonine-protein kinase 2 Q5S006 UniProtKB Repeat 983 1004 . . . Note=LRR 1 Q5S006 UniProtKB Repeat 1012 1033 . . . Note=LRR 2 Q5S006 UniProtKB Repeat 1036 1057 . . . Note=LRR 3 Q5S006 UniProtKB Repeat 1059 1080 . . . Note=LRR 4 Q5S006 UniProtKB Repeat 1084 1105 . . . Note=LRR 5 Q5S006 UniProtKB Repeat 1108 1129 . . . Note=LRR 6 Q5S006 UniProtKB Repeat 1130 1151 . . . Note=LRR 7 Q5S006 UniProtKB Repeat 1174 1195 . . . Note=LRR 8 Q5S006 UniProtKB Repeat 1197 1218 . . . Note=LRR 9 Q5S006 UniProtKB Repeat 1221 1242 . . . Note=LRR 10 Q5S006 UniProtKB Repeat 1246 1267 . . . Note=LRR 11 Q5S006 UniProtKB Repeat 1269 1291 . . . Note=LRR 12 Q5S006 UniProtKB Domain 1328 1511 . . . Note=Roc;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00758 Q5S006 UniProtKB Domain 1879 2146 . . . Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 Q5S006 UniProtKB Repeat 2139 2183 . . . Note=WD 1 Q5S006 UniProtKB Repeat 2188 2228 . . . Note=WD 2 Q5S006 UniProtKB Repeat 2233 2276 . . . Note=WD 3 Q5S006 UniProtKB Repeat 2281 2327 . . . Note=WD 4 Q5S006 UniProtKB Repeat 2333 2377 . . . Note=WD 5 Q5S006 UniProtKB Repeat 2402 2438 . . . Note=WD 6 Q5S006 UniProtKB Repeat 2443 2497 . . . Note=WD 7 Q5S006 UniProtKB Region 957 979 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q5S006 UniProtKB Coiled coil 9 33 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255 Q5S006 UniProtKB Compositional bias 958 979 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q5S006 UniProtKB Active site 1994 1994 . . . Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027 Q5S006 UniProtKB Binding site 1341 1348 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00758 Q5S006 UniProtKB Binding site 1885 1893 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 Q5S006 UniProtKB Binding site 1906 1906 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 Q5S006 UniProtKB Binding site 2098 2121 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00758 Q5S006 UniProtKB Binding site 2295 2298 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00758 Q5S006 UniProtKB Modified residue 910 910 . . . Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5S007 Q5S006 UniProtKB Modified residue 935 935 . . . Note=Phosphoserine;Ontology_term=ECO:0000269,ECO:0007744;evidence=ECO:0000269|PubMed:26824392,ECO:0007744|PubMed:21183079;Dbxref=PMID:21183079,PMID:26824392 Q5S006 UniProtKB Modified residue 955 955 . . . Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5S007 Q5S006 UniProtKB Modified residue 973 973 . . . Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5S007 Q5S006 UniProtKB Modified residue 1292 1292 . . . Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5S007 Q5S006 UniProtKB Modified residue 1444 1444 . . . Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5S007 Q5S006 UniProtKB Mutagenesis 1441 1441 . . . Note=Impaired ability to recruit SEC61A and SEC31A to endoplasmic reticulum exit sites. Impaired ability to regulate ER to Golgi vesicle-mediated transport. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25201882;Dbxref=PMID:25201882 Q5S006 UniProtKB Mutagenesis 1441 1441 . . . Note=Increases kinase activity. Reduces primary ciliogenesis. Causes fragmentation of the trans-Golgi network. R->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:29125462,ECO:0000269|PubMed:29212815,ECO:0000269|PubMed:30398148;Dbxref=PMID:29125462,PMID:29212815,PMID:30398148 Q5S006 UniProtKB Mutagenesis 2016 2016 . . . Note=Does not affect kinase activity and decreases sensitivity towards small molecule kinase inhibitors. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26824392;Dbxref=PMID:26824392 Q5S006 UniProtKB Mutagenesis 2019 2019 . . . Note=Increases kinase activity. Causes loss of dopaminergic neurons in the substantia nigra of 20-month old mice due to increased phosphorylation of APP. Reduces primary ciliogenesis. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26824392,ECO:0000269|PubMed:28720718,ECO:0000269|PubMed:29125462;Dbxref=PMID:26824392,PMID:28720718,PMID:29125462 Q5S006 UniProtKB Sequence conflict 343 343 . . . Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q5S006 UniProtKB Sequence conflict 777 777 . . . Note=V->I;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q5S006 UniProtKB Sequence conflict 863 863 . . . Note=K->N;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q5S006 UniProtKB Sequence conflict 925 925 . . . Note=C->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q5S006 UniProtKB Sequence conflict 1705 1707 . . . Note=WSR->GQD;Ontology_term=ECO:0000305;evidence=ECO:0000305